Journal of Intensive Medicine (Jul 2021)

Understanding COVID-19-associated coagulopathy: From PIC to SIC or DIC

  • Zhong Wang,
  • Xiang Gao,
  • He Miao,
  • Xiaochun Ma,
  • Renyu Ding

DOI
https://doi.org/10.1016/j.jointm.2021.03.002
Journal volume & issue
Vol. 1, no. 1
pp. 35 – 41

Abstract

Read online

Coagulopathy, characterized by a high D-dimer level, is a common pathological occurrence in coronavirus disease 2019 (COVID-19) and is associated with poor prognosis. Severe cases with COVID-19 is associated with a significantly higher risk of deep vein thrombosis and acute pulmonary embolism. Pulmonary intravascular coagulopathy is the characteristic coagulopathy in COVID-19. Unlike sepsis-induced coagulopathy and disseminated intravascular coagulation, which are manifestations of systemic coagulopathy, pulmonary intravascular coagulopathy is a manifestation of a local coagulation disorder in the lung. The progression from pulmonary intravascular coagulopathy to sepsis-induced coagulopathy or disseminated intravascular coagulation in the context of COVID-19 may indicate that the patient's coagulation dysfunction has progressed from local to systemic. Exploring the associated coagulation disease will aid in the understanding of the pathophysiological mechanisms underlying severe COVID-19.

Keywords